Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 170
Selected: 0
NCT IDTitle
NCT03229278Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
NCT00899808Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer
NCT07210567Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
NCT00176644Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
NCT00909909Radiation Therapy in Treating Women With Early Stage Breast Cancer
NCT06518837Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT00749437Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
NCT04929899Bright Ideas - CIN Feasibility Study
NCT02621398Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
NCT04871516Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer
NCT07348679Cigarette Filter Study
NCT06002282HPV Vaccine Confident Families
NCT03257163Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer
NCT00323362Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
NCT01649947Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
NCT01652014Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
NCT02400190The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NCT00138151Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
NCT02144675Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
NCT04081688Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
NCT01617161Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
NCT01006369Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
NCT02177838Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
NCT00962845Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
NCT00118066Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia
NCT00176527Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT01417286Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
NCT01009931Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
NCT00878657Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer
NCT00991315Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
NCT01951807Psychological Interventions for Gynecologic Cancer
NCT01694589A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer
NCT03428802Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
NCT04141449A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
NCT04972019Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study
NCT00118053Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
NCT02699983eHealth Weight Loss Program in African American Breast Cancer Survivors
NCT01951534Decisional Aid Intervention for Women Considering Breast Reconstruction
NCT00934895Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
NCT06704295High Impact E-cigarette Advertisement Features
NCT02324621Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors
NCT00119314Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
NCT00496366Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer
NCT00176605Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
NCT00578240Molecular Studies and Clinical Correlations in Human Prostatic Disease
NCT00866840Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
NCT01794676Genetic Evaluation of Families With Endocrine Cancers
NCT01828476Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer
NCT02203578Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease
NCT03102060Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant